Clinical trials
Graves Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Harbin Medical University | 3 |
| National Taiwan University Hospital | 3 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2 |
| The University of Hong Kong | 2 |
| Central Hospital, Nancy, France | 1 |
| Clinical Research Centre, Malaysia | 1 |
| Mashhad University of Medical Sciences | 1 |
| Medical University of Silesia | 1 |
| Medical University of Vienna | 1 |
| Qilu Hospital of Shandong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Disease | 22 |
| Hyperthyroidism | 5 |
| Graves Ophthalmopathy | 4 |
| Thyroid Diseases | 4 |
| Hashimoto Disease | 3 |
| Autoimmune Diseases | 2 |
| Celiac Disease | 2 |
| Vitiligo | 2 |
| Addison Disease | 1 |
| Alopecia Areata | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.